Patents by Inventor Kenneth Laderman

Kenneth Laderman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alpha-amylase from hyperthermophilic archaebacterium
    Patent number: 5578479
    Abstract: The present invention relates, in general, to .alpha.-amylase, and, in particular to .alpha.-amylase from a hyperthermophilic archaebacterium, wherein said .alpha.-amylase is in pure form. The invention also relates to a method of purifying a hyperthermophilic .alpha.-amylase.
    Type: Grant
    Filed: June 9, 1992
    Date of Patent: November 26, 1996
    Assignee: The Johns Hopkins University
    Inventors: Kenneth Laderman, Christian B. Anfinsen
  • .alpha.-amylase gene
    Patent number: 5366883
    Abstract: The present invention relates, in general, to a cloned .alpha.-amylase gene, and, in particular, to a cloned hyperthermophilic .alpha.-amylase gene and to methods of producing .alpha.-amylase using same.
    Type: Grant
    Filed: June 9, 1992
    Date of Patent: November 22, 1994
    Assignees: Takara Shuzo Co., Ltd., The Johns Hopkins University
    Inventors: Kiyozo Asada, Takashi Uemori, Hiroyuki Mukai, Ikunoshin Kato, Kenneth Laderman, Christian B. Anfinsen
  • Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
    Patent number: 5078997
    Abstract: The present invention is a pharmaceutical composition for proteins which are not stably soluble. The preferred protein is IL-2 and the preferred composition includes amino acids, vitamins, polymers, fatty acids or low molecular weight acids.
    Type: Grant
    Filed: April 18, 1989
    Date of Patent: January 7, 1992
    Assignee: Cetus Corporation
    Inventors: Maninder S. Hora, Nandini Katre, Kenneth A. Laderman